The Online Investor
Medical Instruments & Supplies M&A image Medical Instruments & Supplies M&A » By The Online Investor Staff, updated Thu., Apr. 18, 11:52 AM Recent mergers and acquisitions in the Medical Instruments & Supplies M&A category.

Slide #77. Abbott Laboratories IDEV Technologies

Acquirer: Abbott Laboratories (NYSE:ABT)
Acquiree: IDEV Technologies
Details: RiverVest Venture Partners announced today that Abbott Laboratories is acquiring RiverVest medical device portfolio company IDEV Technologies for $310 million. With the sale of IDEV, life sciences venture capital firm RiverVest has successfully exited six portfolio companies since 2011, generating total acquisition proceeds of more than $1.5 billion, with more than $120 million of these proceeds going to RiverVest funds.

Abbott Laboratories is engaged in the discovery, development, manufacture, and sale of a line of health care products. Co. has four segments: Established Pharmaceutical Products, which includes a line of generic pharmaceuticals; Diagnostic Products, which includes a line of diagnostic systems and tests; Nutritional Products, which includes a line of pediatric and adult nutritional products; and Medical Devices, which includes a line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders.

Abbott Laboratories SEC Filing Email Alerts Service


Open the ABT Page at The Online Investor »

Company Name: 
Abbott Laboratories
Stock buyback: 
ABT buyback
Website: 
www.abbottinvestor.com
Sector: 
Medical Instruments & Supplies
Number of ETFs Holding ABT: 
119
Total Market Value Held by ETFs: 
$23.69B
Total Market Capitalization: 
$189.59B
% of Market Cap. Held by ETFs: 
12.50%
 

Open the ABT Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Email EnvelopeFree ABT Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Buy (3.47 out of 4)
100th percentile
(ranked higher than approx. 100% of all stocks covered)

Analysts' Target Price:
ABT Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Medical Instruments & Supplies M&A - Slide 77 of 100 Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2024, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.